- Tytuł:
- Dual EGFR and ABL Tyrosine Kinase Inhibitor Treatment in a Patient with Concomitant EGFR-Mutated Lung Adenocarcinoma and BCR-ABL1-Positive CML.
- Autorzy:
- Temat:
-
PROTEIN-tyrosine kinases
KINASE inhibitors
CHRONIC myeloid leukemia
ADENOCARCINOMA
LUNGS - Źródło:
- Case Reports in Oncological Medicine; 3/19/2020, p1-6, 6p
Czasopismo naukowe